Sign in

CIK 0001867066 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Journey Medical Corp

Sign in to watch
Ticker
DERM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471879539
Phone
480-434-6670
Business address
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE, AZ, 85258
  1. 4 Grant or award Director acquired 7,173 shares (grant or award)
  2. 4 Grant or award Director acquired 7,173 shares (grant or award)
  3. 4 Grant or award Chief Operating Officer acquired 46,863 shares (grant or award)
  4. 4 Grant or award CFO acquired 28,907 shares (grant or award)
  5. 4 Grant or award President & CEO acquired 49,277 shares (grant or award)
  6. 4 Open-market sale President & CEO sold 4,834 shares at $6.84 ($33,065)
  7. 4 Open-market sale CFO sold 2,409 shares at $6.84 ($16,478)
  8. 4 Open-market sale COO sold 2,857 shares at $6.84 ($19,542)
  9. 4 Grant or award President & CEO acquired 350,000 shares (grant or award)
  10. 4 Grant or award CFO acquired 160,000 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale President & CEO sold 49,271 shares at $5.01 ($246,848)
  13. 4 Open-market sale President & CEO sold 40,456 shares at an average $5.03 ($203,451)
  14. 4 Open-market sale President & CEO sold 70,556 shares at an average $5.11 ($360,762)
  15. 4 Open-market sale CFO sold 1,365 shares at $5.19 ($7,084)
  16. 4 Open-market sale CFO sold 9,324 shares at $5.47 ($51,002)
  17. 4 Grant or award Director acquired 30,000 shares (grant or award)
  18. 4 Open-market sale CFO sold 4,055 shares at $5.40 ($21,897)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Grant or award Director acquired 9,728 shares (grant or award)

Page 2 of 5 · 88 filings